Decreased Warburg effect induced by ATP citrate lyase suppression inhibits tumor growth in pancreatic cancer

• Published in: Medical oncology (Northwood, London, England) London, England), 2015-03, Vol.32 (3), p.85-85
• Main Authors: Zong, Haifeng, Zhang, Yang, You, Yong, Cai, Tiantian, Wang, Yehuang
• Format: Article
• Language: English
• Subjects: Oncology; Pancreatic cancer
• ISSN: 1357-0560; 1559-131X
• DOI: 10.1007/s12032-015-0540-z

ATP citrate lyase (ACLY) is responsible for the conversion of cytosolic citrate into acetyl-CoA and oxaloacetate, and the first rate-limiting enzyme involved in de novo lipogenesis. Recent studies have demonstrated that inhibition of elevated ACLY results in growth arrest and apoptosis in a subset of cancers; however, the expression pattern and underlying biological function of ACLY in pancreatic ductal adenocarcinoma (PDAC) remains unclear. In the current study, overexpressed ACLY was more commonly observed in PDAC compared to normal pancreatic tissues. Kaplan-Meier survival analysis showed that high expression level of ACLY resulted in a poor prognosis of PDAC patients. Silencing of endogenous ACLY expression by siRNA in PANC-1 cells led to reduced cell viability and increased cell apoptosis. Furthermore, significant decrease in glucose uptake and lactate production was observed after ACLY was knocked down, and this effect was blocked by 2-deoxy-D-glucose, indicating that ACLY functions in the Warburg effect affect PDAC cell growth. Collectively, this study reveals that suppression of ACLY plays an anti-tumor role through decreased Warburg effect, and ACLY-related inhibitors might be potential therapeutic approaches for PDAC.